Comparative Study
doi: 10.1007/BF01964256.
Comparative in vitro activity of the new oxacephem antibiotic, flomoxef (6315-S)
Affiliations
- PMID: 3143586
- DOI: 10.1007/BF01964256
Item in Clipboard
Comparative Study
Comparative in vitro activity of the new oxacephem antibiotic, flomoxef (6315-S)
Eur J Clin Microbiol Infect Dis.
1988 Oct.
Abstract
The in vitro activity of flomoxef (6315-S) was determined and compared to that of different cephalosporins against 787 clinical isolates of staphylococci, Enterobacteriaceae and anaerobes. Flomoxef is similar in activity to latamoxef and cefotaxime against Enterobacteriaceae, slightly more active than cephalothin and cefamandole against oxacillin-sensitive strains of Staphylococcus aureus and minimally less active than cefamandole against oxacillin-resistant strains. Flomoxef showed similar or better activity than latamoxef and cefoxitin against most of the anaerobic species of medical importance.
Similar articles
-
In vitro activity of flomoxef in comparison to other cephalosporins.Infection. 1988 Mar-Apr;16(2):131-4. doi: 10.1007/BF01644322. Infection. 1988. PMID: 3372024
-
["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].Pathol Biol (Paris). 1979 Dec;27(10):649-54. Pathol Biol (Paris). 1979. PMID: 395496 French.
-
The in vitro activity of cefamandole against 3312 bacterial isolates. A Norwegian multicentre study.NIPH Ann. 1980 Dec;3(2):141-7. NIPH Ann. 1980. PMID: 7219840
-
Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens).Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):43-8. doi: 10.1016/0732-8893(95)00042-9. Diagn Microbiol Infect Dis. 1995. PMID: 7587049 Review.
-
Use of third-generation cephalosporins. Anaerobes.Hosp Pract (Off Ed). 1991;26 Suppl 4:11-7; discussion 48. doi: 10.1080/21548331.1991.11707729. Hosp Pract (Off Ed). 1991. PMID: 1918210 Review.
Cited by
-
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.Paediatr Drugs. 2021 Sep;23(5):465-484. doi: 10.1007/s40272-021-00465-z. Epub 2021 Aug 26. Paediatr Drugs. 2021. PMID: 34435316 Free PMC article. Review.